Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
2018 EIT Innovators Award Winner Ioannis Tarnanas | EIT
Ioannis Tarnanas's email & phone | Altoida's Founder email
Altoida secures funding and research partnership with Eisai Innovation – Venturelab
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Cognitive Health & Digital Biomarker Technologies | Altoida
Cognitive Health & Digital Biomarker Technologies | Altoida
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient
Ioannis Tarnanas | Nature Portfolio Health Community
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas - Worldwebforum
